Time exploration of initiating letermovir for the prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.

Prevymis (letermovir) - Merck (MSD)

Time exploration of initiating letermovir for the prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. (PubMed, Chin Med J (Engl)) - Apr 14, 2026 - No abstract available
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Infectious Disease • Transplantation

http://www.ncbi.nlm.nih.gov/pubmed/41978318

Jingjing Heng; Luxiang Wang; Mengyang Zhu; Ni Liao; Ran Zhang; Wei Shi; Weijie Cao; Xiaoxia Hu; Xueqi Xie; Yang Cao; Zhilei Bian

Apr 14, 2026